{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:14:15Z","timestamp":1791213255828,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T00:00:00Z","timestamp":1427587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10571-015-0176-8","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T07:06:42Z","timestamp":1427612802000},"page":"755-761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Gaucher-Associated Parkinsonism"],"prefix":"10.1007","volume":"35","author":[{"given":"Yaqiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,29]]},"reference":[{"key":"176_CR1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0891988710383572","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM, Mata IF, Zabetian CP (2010) The genetics of Parkinson disease. J Geriatr Psychiatry Neurol 23:228\u2013242","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"176_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","volume":"61","author":"B Bembi","year":"2003","unstructured":"Bembi B, Zambito Marsala S, Sidransky E, Ciana G, Carrozzi M, Zorzon M et al (2003) Gaucher\u2019s disease with Parkinson\u2019s disease: clinical and pathological aspects. Neurology 61:99\u2013101","journal-title":"Neurology"},{"key":"176_CR3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bcmd.2005.07.005","volume":"35","author":"E Beutler","year":"2005","unstructured":"Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35:355\u2013364","journal-title":"Blood Cells Mol Dis"},{"key":"176_CR4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","volume":"77","author":"K Brockmann","year":"2011","unstructured":"Brockmann K, Srulijes K, Hauser AK, Schulte C, Csoti I, Gasser T, Berg D (2011) GBA-associated PD presents with nonmotor characteristics. Neurology 77:276\u2013280","journal-title":"Neurology"},{"key":"176_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-7-12","volume":"7","author":"TN Campbell","year":"2012","unstructured":"Campbell TN, Choy FY (2012) Gaucher disease and the synucleinopathies: refining the relationship. Orphanet J Rare Dis 7:12","journal-title":"Orphanet J Rare Dis"},{"key":"176_CR6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364:1167\u20131169","journal-title":"Lancet"},{"key":"176_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","volume":"104","author":"JH Choi","year":"2011","unstructured":"Choi JH, Stubblefield B, Cookson MR, Goldin E, Velayati A, Tayebi N et al (2011) Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations. Mol Genet Metab 104:185\u2013188","journal-title":"Mol Genet Metab"},{"key":"176_CR8","first-page":"150450","volume":"2011","author":"FY Choy","year":"2011","unstructured":"Choy FY, Campbell TN (2011) Gaucher disease and cancer: concept and controversy. Int J Cell Biol 2011:150450","journal-title":"Int J Cell Biol"},{"key":"176_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bcmd.2006.11.003","volume":"38","author":"FY Choy","year":"2007","unstructured":"Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N et al (2007) Gaucher disease among Chinese patients: review on genotype\/phenotype correlation from 29 patients and identification of novel and rare alleles. Blood Cells Mol Dis 38:287\u2013293","journal-title":"Blood Cells Mol Dis"},{"key":"176_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.20320","volume":"20","author":"LN Clark","year":"2005","unstructured":"Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L et al (2005) Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson\u2019s disease in subjects of Jewish ethnicity. Mov Disord 20:100\u2013103","journal-title":"Mov Disord"},{"key":"176_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","volume":"313","author":"AA Cooper","year":"2006","unstructured":"Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models. Science 313:324\u2013328","journal-title":"Science"},{"key":"176_CR12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"176_CR13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/mds.22538","volume":"24","author":"J DePaolo","year":"2009","unstructured":"DePaolo J, Goker-Alpan O, Samaddar T, Lopez G, Sidransky E (2009) The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism. Mov Disord 24:1571\u20131578","journal-title":"Mov Disord"},{"key":"176_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0028-3908(03)00140-0","volume":"45","author":"KK Dev","year":"2003","unstructured":"Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H (2003) Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45:14\u201344","journal-title":"Neuropharmacology"},{"key":"176_CR15","first-page":"65","volume":"3","author":"M do Ros\u00e1rio Almeida","year":"2012","unstructured":"do Ros\u00e1rio Almeida M (2012) Glucocerebrosidase involvement in Parkinson disease and other synucleinopathies. Front Neurol 3:65","journal-title":"Front Neurol"},{"key":"176_CR16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","volume":"23","author":"T Farfel-Becker","year":"2014","unstructured":"Farfel-Becker T, Vitner EB, Kelly SL, Bame JR, Duan J, Shinder V et al (2014) Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum Mol Genet 23:843\u2013854","journal-title":"Hum Mol Genet"},{"key":"176_CR17","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 24:6715\u20136723","journal-title":"J Neurosci"},{"key":"176_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","volume":"166","author":"WP Gai","year":"2000","unstructured":"Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166:324\u2013333","journal-title":"Exp Neurol"},{"key":"176_CR19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T et al (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70:2277\u20132283","journal-title":"Neurology"},{"key":"176_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg ME, Burke D, Heales SJ, Cooper JM, Hardy J, Wood NW, Schapira AH (2012) Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol 72:455\u2013463","journal-title":"Ann Neurol"},{"key":"176_CR21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937\u2013940","journal-title":"J Med Genet"},{"key":"176_CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","volume":"120","author":"O Goker-Alpan","year":"2010","unstructured":"Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E (2010) Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders. Acta Neuropathol 120:641\u2013649","journal-title":"Acta Neuropathol"},{"key":"176_CR23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"GA Grabowski","year":"2008","unstructured":"Grabowski GA (2008) Phenotype, diagnosis, and treatment of Gaucher\u2019s disease. Lancet 372:1263\u20131271","journal-title":"Lancet"},{"key":"176_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","volume":"36","author":"A Halperin","year":"2006","unstructured":"Halperin A, Elstein D, Zimran A (2006) Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 36:426\u2013428","journal-title":"Blood Cells Mol Dis"},{"key":"176_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2009.03.008","volume":"19","author":"J Hardy","year":"2009","unstructured":"Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson\u2019s syndromes: a critical review. Curr Opin Genet Dev 19:254\u2013265","journal-title":"Curr Opin Genet Dev"},{"key":"176_CR26","doi-asserted-by":"crossref","first-page":"78549","DOI":"10.1155\/JBB\/2006\/78549","volume":"2006","author":"KS Hruska","year":"2006","unstructured":"Hruska KS, Goker-Alpan O, Sidransky E (2006) Gaucher disease and the synucleinopathies. J Biomed Biotechnol 2006:78549","journal-title":"J Biomed Biotechnol"},{"key":"176_CR27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska KS, LaMarca ME, Scott CR, Sidransky E (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567\u2013583","journal-title":"Hum Mutat"},{"key":"176_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","volume":"452","author":"K Kalinderi","year":"2009","unstructured":"Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L (2009) Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 452:87\u201389","journal-title":"Neurosci Lett"},{"key":"176_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"176_CR30","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48\u2013R59","journal-title":"Hum Mol Genet"},{"key":"176_CR31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2010","unstructured":"Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C et al (2010) Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum Mol Genet 20:202\u2013210","journal-title":"Hum Mol Genet"},{"key":"176_CR32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 81:70\u201373","journal-title":"Mol Genet Metab"},{"key":"176_CR33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2009.12.007","volume":"469","author":"XY Mao","year":"2010","unstructured":"Mao XY, Burgunder JM, Zhang ZJ, An XK, Zhang JH, Yang Y et al (2010) Association between GBA L444P mutation and sporadic Parkinson\u2019s disease from Mainland China. Neurosci Lett 469:256\u2013259","journal-title":"Neurosci Lett"},{"key":"176_CR34","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi061749a","volume":"46","author":"Z Martinez","year":"2007","unstructured":"Martinez Z, Zhu M, Han SB, Fink AL (2007) GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. Biochemistry 46:1868\u20131877","journal-title":"Biochemistry"},{"key":"176_CR35","first-page":"379","volume":"65","author":"IF Mata","year":"2008","unstructured":"Mata IF, Samii A, Schneer SH, Roberts JW, Griffith A, Leis BC et al (2008) Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 65:379\u2013382","journal-title":"Arch Neurol"},{"key":"176_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA et al (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37\u201352","journal-title":"Cell"},{"key":"176_CR37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp-2012-302402","volume":"83","author":"A McNeill","year":"2012","unstructured":"McNeill A, Duran R, Hughes DA, Mehta A, Schapira AH (2012a) A clinical and family history study of Parkinson\u2019s disease in heterozygous glucocerebrosidase mutation carriers. J Neurol Neurosurg Psychiatry 83:853\u2013854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"176_CR38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.24945","volume":"27","author":"A McNeill","year":"2012","unstructured":"McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A et al (2012b) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord 27:526\u2013532","journal-title":"Mov Disord"},{"key":"176_CR39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A McNeill","year":"2014","unstructured":"McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A et al (2014) Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 137:1481\u20131495","journal-title":"Brain"},{"key":"176_CR40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J et al (2009) Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66:571\u2013576","journal-title":"Arch Neurol"},{"key":"176_CR41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E et al (2014) Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson\u2019s disease. Brain 137:834\u2013848","journal-title":"Brain"},{"key":"176_CR42","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E, O\u2019Sullivan SS, Parkkinen L, Lachmann RH et al (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794","journal-title":"Brain"},{"key":"176_CR43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.parkreldis.2010.09.009","volume":"17","author":"K Nishioka","year":"2011","unstructured":"Nishioka K, Ross OA, Vilari\u00f1o-G\u00fcell C, Cobb SA, Kachergus JM, Mann DM et al (2011) Glucocerebrosidase mutations in diffuse Lewy body disease. Parkinsonism Relat Disord 17:55\u201357","journal-title":"Parkinsonism Relat Disord"},{"key":"176_CR44","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","volume":"17","author":"LD Osellame","year":"2013","unstructured":"Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S et al (2013) Mitochondria and quality control defects in a mouse model of Gaucher disease\u2014links to Parkinson\u2019s disease. Cell Metab 17:941\u2013953","journal-title":"Cell Metab"},{"key":"176_CR45","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15:S14\u2013S20","journal-title":"Eur J Neurol"},{"key":"176_CR46","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"176_CR47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","volume":"46","author":"B Rosenbloom","year":"2011","unstructured":"Rosenbloom B, Balwani M, Bronstein JM, Kolodny E, Sathe S, Gwosdow AR et al (2011) The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol Dis 46:95\u2013102","journal-title":"Blood Cells Mol Dis"},{"key":"176_CR48","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/mds.21076","volume":"21","author":"GW Ross","year":"2006","unstructured":"Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J et al (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21:2062\u20132067","journal-title":"Mov Disord"},{"key":"176_CR49","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","volume":"111","author":"M Rothaug","year":"2014","unstructured":"Rothaug M, Zunke F, Mazzulli JR, Schweizer M, Altmeppen H, L\u00fcllmann-Rauch R et al (2014) LIMP-2 expression is critical for \u03b2-glucocerebrosidase activity and \u03b1-synuclein clearance. Proc Natl Acad Sci USA 111:15573\u201315578","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR50","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","volume":"108","author":"SP Sardi","year":"2011","unstructured":"Sardi SP, Clarke J, Kinnecom C, Tamsett TJ, Li L, Stanek LM et al (2011) CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc Natl Acad Sci USA 108:12101\u201312106","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR51","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","volume":"110","author":"SP Sardi","year":"2013","unstructured":"Sardi SP, Clarke J, Viel C, Chan M, Tamsett TJ, Treleaven CM et al (2013) Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. Proc Natl Acad Sci USA 110:3537\u20133542","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR52","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.1300822110","volume":"110","author":"AH Schapira","year":"2013","unstructured":"Schapira AH, Gegg ME (2013) Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease. Proc Natl Acad Sci USA 110:3214\u20133215","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR53","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","volume":"26","author":"T Shachar","year":"2011","unstructured":"Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH (2011) Lysosomal storage disorders and Parkinson\u2019s disease: Gaucher disease and beyond. Mov Disord 26:1593\u20131604","journal-title":"Mov Disord"},{"key":"176_CR54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11:986\u2013998","journal-title":"Lancet Neurol"},{"key":"176_CR55","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"key":"176_CR56","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","volume":"137","author":"M Siebert","year":"2014","unstructured":"Siebert M, Sidransky E, Westbroek W (2014) Glucocerebrosidase is shaking up the synucleinopathies. Brain 137:1304\u20131322","journal-title":"Brain"},{"key":"176_CR57","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J et al (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"176_CR58","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1194\/jlr.R047381","volume":"55","author":"E Sybertz","year":"2014","unstructured":"Sybertz E, Krainc D (2014) Development of targeted therapies for Parkinson disease and related synucleinopathies. J Lipid Res 55:1996\u20132003","journal-title":"J Lipid Res"},{"key":"176_CR59","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104\u2013109","journal-title":"Mol Genet Metab"},{"key":"176_CR60","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.E09-09-0801","volume":"21","author":"N Thayanidhi","year":"2010","unstructured":"Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, Hay JC (2010) Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs. Mol Biol Cell 21:1850\u20131863","journal-title":"Mol Biol Cell"},{"key":"176_CR61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138920309789351921","volume":"10","author":"VN Uversky","year":"2009","unstructured":"Uversky VN, Eliezer D (2009) Biophysics of Parkinson\u2019s disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci 10:483\u2013499","journal-title":"Curr Protein Pept Sci"},{"key":"176_CR62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","volume":"20","author":"EB Vitner","year":"2014","unstructured":"Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD et al (2014) RIPK3 as a potential therapeutic target for Gaucher\u2019s disease. Nat Med 20:204\u2013208","journal-title":"Nat Med"},{"key":"176_CR63","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2353\/ajpath.2009.080680","volume":"174","author":"J Wei","year":"2009","unstructured":"Wei J, Fujita M, Nakai M, Waragai M, Sekigawa A, Sugama S et al (2009) Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies. Am J Pathol 174:1891\u20131909","journal-title":"Am J Pathol"},{"key":"176_CR64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","volume":"17","author":"W Westbroek","year":"2011","unstructured":"Westbroek W, Gustafson AM, Sidransky E (2011) Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol Med 17:485\u2013493","journal-title":"Trends Mol Med"},{"key":"176_CR65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp.2008.155895","volume":"80","author":"SS Williams","year":"2009","unstructured":"Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R (2009) Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 80:667\u2013670","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"176_CR66","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK et al (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82:192\u2013207","journal-title":"Mol Genet Metab"},{"key":"176_CR67","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","volume":"286","author":"TL Yap","year":"2011","unstructured":"Yap TL, Gruschus JM, Velayati A, Westbroek W, Goldin E, Moaven N et al (2011) Alpha-synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases. J Biol Chem 286:28080\u201328088","journal-title":"J Biol Chem"},{"key":"176_CR68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","volume":"108","author":"TL Yap","year":"2013","unstructured":"Yap TL, Velayati A, Sidransky E, Lee JC (2013) Membrane-bound \u03b1-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Mol Genet Metab 108:56\u201364","journal-title":"Mol Genet Metab"},{"key":"176_CR69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I et al (2004) The new mutation, E46\u00a0K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"176_CR70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","volume":"91","author":"SG Ziegler","year":"2007","unstructured":"Ziegler SG, Eblan MJ, Gutti U, Hruska KS, Stubblefield BK, Goker-Alpan O et al (2007) Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 91:195\u2013200","journal-title":"Mol Genet Metab"},{"key":"176_CR71","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awu143","volume":"137","author":"N Zokaei","year":"2014","unstructured":"Zokaei N, McNeill A, Proukakis C, Beavan M, Jarman P, Korlipara P et al (2014) Visual short-term memory deficits associated with GBA mutation and Parkinson\u2019s disease. Brain 137:2303\u20132311","journal-title":"Brain"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-015-0176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-015-0176-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-015-0176-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:53:04Z","timestamp":1553640784000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-015-0176-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,29]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s10571-015-0176-8","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,29]]}}}